"The ABU is committed to evolving a [life-long learning] program that diplomates find relevant and less burdensome. We will always welcome diplomates’ feedback regarding this evolving program," writes H. Ballentine Carter, MD.
H. Ballentine Carter, MD
Advertisement
Articles by H. Ballentine Carter, MD
Advertisement
Latest Updated Articles
- ABU: Life-long learning will be relevant, less burdensome
November 1st 2017
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves capivasertib plus abiraterone and prednisone for PTEN-deficient mHSPC
2
Dean Elterman, MD, highlights efficacy and safety data on the Zenflow Prostatic Spring
3
FDA approves adjuvant belzutifan with pembrolizumab for ccRCC
4
Toni Choueiri, MD, reacts to FDA approval of adjuvant belzutifan with pembrolizumab for ccRCC
5